EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry
Vienna, Austria August 27-31, 2017
Novartis, South San Francisco, United States
ETH Zürich, Zürich, Switzerland
University of Antwerp, Antwerp, Belgium
University of Vienna, Vienna, Austria
Chembridge Corporation, San Diego, United States
Temple University, Philadelphia, United States
Merck Biopharma, Darmstadt, Germany
University of Cambridge, Cambridge, United Kingdom
Technion-Israel Institute of Technology, Haifa, Israel
Novartis, Basel, Switzerland
RICE University, Houston, United States
Eli Lilly & Co.
Institut de Recherches Servier, Croissy sur Seine, France
UCB, Braine-l'Alleud, Belgium
F. Hoffmann-La Roche, Schlieren, Switzerland
Max Planck Institute of Colloids and Interfaces, Berlin, Germany
Novo Nordisk, Cambridge, United States
Pfizer, New-York, United States
Janssen Infectious Diseases, Beerse, Belgium